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Synthetic biology can be defined as the design and
construction of novel biologically based parts, devices
and systems, as well as the redesign of existing natural
biological systems, for useful purposes. It builds on genetic
engineering, being design-driven genetic engineering
encompassing engineering concepts of standardization
and abstraction (Endy, 2005). One of the technical
advances that has significantly increased the ability to
undertake synthetic biology has been to artificially
synthesize DNA, and thus create DNA parts. So far, the
peak achievement has been the synthesis and assembly of a
small bacterial genome which was transferred to a bacterial
cell devoid of DNA to create a novel replicating micro-
organism (Gibson et al., 2010). A great diversity of
synthetic biology applications exists, many in the early
research phase, which include using microbes as biofac-
tories or as biological computers (Bonnet et al., 2012;
Oldham et al., 2012). In this issue of Microbiology we have
assembled a collection of papers to showcase the current
state of synthetic biology research, and to convey the
potential impact of synthetic biology on biological sciences.
The synthetic biology field itself is diverse but can broadly
be divided into two main themes: bottom-up approaches
creating truly artificial life de novo, and top-down
approaches to design systems based on known biology to
perform a specific task. The latter can involve designing
metabolic and signalling pathways inside cells to achieve a
specific purpose. Within this top-down design, biological
elements (promoters, gene products, etc.) can be thought
of as parts being assembled into a system. The top-down
approach has the advantage of using the host cell (termed
the chassis) and being able to make use of the co-factors,
metabolites, transcription pathways and other components
that it already possesses, but does have the potential
disadvantage of potential crosstalk between the endogen-
ous systems present in the chassis and the introduced
synthetic systems (Saito, 2010; Verhamme et al., 2002). The
papers within this issue focus on the top-down approach.
As the aim of synthetic biology is to design a system to
achieve a required outcome, researchers rely heavily on in
silico modelling and whole-system analysis (’omic analysis)
to provide data about the effect of perturbations, allowing
parts encoded in DNA to be characterized and optimized.
The data provide the basis to bring component parts
together in different combinations to produce predictable
devices with the outcomes predicted through modelling.
An example of developing these standard parts is given in
the Bartosiak-Jentys et al. (2013) paper, which describes the
creation of a modular system for the design of Geobacillus
and defins the parts that are created. The authors also
describe how this may be applied in the design of improved
bioethanol-producing strains. The parts themselves can be
specifically modified to alter the desired outcome. The
review in this issue by Arpino et al. (2013) describes these
design parameters and how they can be modified in both
prokaryote and eukaryote microbial systems. For example,
different ribosome-binding sites can alter protein copy
number, resulting in different outcomes from the synthetic
system. Once defined, there is the ability to add these parts
together to produce a system with a predictable defined
output. A nice example of how using a small range of
defined parts can be used to generate complex outcomes is
presented by Chang et al. (2013). Here the authors use a
simple bacterial two-component system to produce a range
of outputs through careful variation of a phosphatase. This
paper also highlights the utility of model-based design.
Such technology has huge potential applications in
industry. Being able to synthesize products in a biologically
controlled way opens up new methods of manufacture, as
highlighted in the Donald et al. (2013) paper. In this work
the authors describe how expression can be optimized
using synthetic biological approaches to modify the chassis,
in this case to produce a vaccine.
Synthetic biology has been identified as a technology that
has huge potential to transform the way we work, and this
step change in our use of biology has been recognized not
just in the scientific community but in the wider social
sphere as well. As a result, a number of governments have
been shaping policy and developing science funding to
specifically support synthetic biology (Pei et al., 2012;
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Zhang, 2011). In particular, how does current international
legislation apply to synthetic biology (Bubela et al., 2012)?
In the UK, for example, a cross-government group (The
Synthetic Biology Roadmap Coordination Group, 2012)
developed the Synthetic Biology Roadmap to bring
together all the different interested parties and communit-
ies and to identify what government support is needed to
develop this science within the UK, both for pure
understanding and to drive translational research. The
Roadmap also considered approaches to the ethical and
legal issues. These latter areas have been raised as a matter
of concern in a number of countries, and highlighted
recently in the US (Roehr, 2010), reflecting the ethical,
safety and regulatory considerations that apply to any new
technology but, given the potential for self-replication,
have particular significance in synthetic biology. With the
emphasis on making manipulation of biology easier,
synthetic biology also raises significant implications of
dual use of synthetic biology for nefarious purposes, which
also need consideration in ethical, legal and regulatory
contexts (Samuel et al., 2009). Such considerations have
also been the basis of activity within national learned
academies, culminating in the six academies symposia
between the science and engineering academies of the UK,
China and the US. These meetings resulted in opinion
pieces regarding ways of progressing synthetic biology
research for the benefit of humanity while avoiding the
potential pitfalls (OECD & The Royal Society, 2011). These
issues will become especially important if we consider the
possible environmental release of biological devices.
Developing methods to contain and control the biological
devices that we produce is thus a significant area of
research. A review article in this issue by Wright et al.
(2013) looks at current research in this area, and how
scientific solutions can give us control over the spread of
the synthetic systems we design.
As indicated above, synthetic biology is a priority area for
funding in a number of countries. This is now evolving
into an internationally structured area, with larger
international research networks being established, such as
the EraSynBio network between funding bodies in both
Europe and the US. Just as the technology requires a multi-
disciplinary effort, so the science requires an international
approach and frameworks. If, for example, there are to be
standardized biological parts, such as using the Biobricks
standard (Canton et al., 2008), researchers will have to
work together, and within their domestic regulations, to
achieve that.
The articles published in this issue highlight the promise
and hurdles that synthetic biology must overcome to
produce the future designer microbes that could transform
our world. Quite what that future will be is left for the
reader to imagine, but there can be no doubt synthetic
biology will play an important role.
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